Back to Search
THOMAS GROGAN, M.D.
M.D.
Anesthesiology Physician
NPI: 1821250895IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
249311(NY)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Class of 2007
Research & Publications (20)
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.
PMID 18645482·Transplantation·2008
3-trial
Direct multiplexed measurement of gene expression with color-coded probe pairs.
PMID 18278033·Nat Biotechnol·2008
8-other
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.
PMID 18544678·Blood·2008
8-other
Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH).
PMID 18945356·Diagn Pathol·2008
8-other
A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility.
PMID 17536315·Appl Immunohistochem Mol Morphol·2007
4-observational
The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts.
PMID 17094016·J Mol Histol·2007
7-preclinical
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
PMID 17299095·Blood·2007
8-other
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
PMID 17296973·J Clin Oncol·2007
8-other
Genotyping of phenotypically defined cells in neoplasia: enhanced immunoFISH via tyramide signal amplification (TSA) segregates immunophenotypically-defined cell populations for gated genotyping.
PMID 17205377·J Mol Histol·2007
8-other
Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma.
PMID 17700562·Lab Invest·2007
8-other
Automation of manual components and image quantification of direct dual label fluorescence in situ hybridization (FISH) for HER2 gene amplification: A feasibility study.
PMID 17122642·Appl Immunohistochem Mol Morphol·2006
8-other
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.
PMID 16239429·Blood·2006
8-other
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
PMID 16418494·J Clin Oncol·2006
8-other
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival.
PMID 16543468·Blood·2006
8-other
Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival.
PMID 17149956·Arch Pathol Lab Med·2006
8-other
High-resolution immunophenotyping of subcellular compartments in tissue microarrays by enzyme metallography.
PMID 16280669·Appl Immunohistochem Mol Morphol·2005
4-observational
Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
PMID 16373702·Mol Cancer Ther·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1320 W MAIN ST
NEWARK, OH 43055 - Phone
- (220) 564-4218
Quick Facts
- NPI
- 1821250895
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile